BioNexus Gene Lab Corp. Increase (Decrease) in Other Accounts Payable
BioNexus Gene Lab Corp. (BGLC) reported Increase (Decrease) in Other Accounts Payable of $187.89 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayable · last filed 2026-05-15
- BioNexus Gene Lab Corp. increase (decrease) in other accounts payable for the quarter ending 2026-03-31 was $187.89K.
- BioNexus Gene Lab Corp. increase (decrease) in other accounts payable for the quarter ending 2025-12-31 was -$156.03K, a 133.76% decline year-over-year.
- BioNexus Gene Lab Corp. increase (decrease) in other accounts payable for the quarter ending 2025-09-30 was -$1.11M, a 655.80% decline year-over-year.
- BioNexus Gene Lab Corp. increase (decrease) in other accounts payable for the quarter ending 2025-06-30 was $204.96K.
- BioNexus Gene Lab Corp. increase (decrease) in other accounts payable for fiscal 2025 was -$1.38M, a 777.05% decline from fiscal 2024.
- BioNexus Gene Lab Corp. increase (decrease) in other accounts payable for fiscal 2024 was $204.34K.
- BioNexus Gene Lab Corp. increase (decrease) in other accounts payable for fiscal 2023 was -$381.29K.
- BioNexus Gene Lab Corp. increase (decrease) in other accounts payable for fiscal 2022 was -$119.69K.
| Period end | Increase (Decrease) in Other Accounts Payable 3 month | Increase (Decrease) in Other Accounts Payable 3 month as first filed | Increase (Decrease) in Other Accounts Payable 6 month | Increase (Decrease) in Other Accounts Payable 6 month as first filed | Increase (Decrease) in Other Accounts Payable 9 month | Increase (Decrease) in Other Accounts Payable 9 month as first filed | Increase (Decrease) in Other Accounts Payable 12 month |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | $187.89K 10-Q · filed 2026-05-15 | $31.86K derived: sum of 2 quarters · filed 2026-05-15 | -$1.08M derived: sum of 3 quarters · filed 2026-05-15 | -$878.08K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2025-12-31 | -$156.03K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | -$1.27M derived: sum of 2 quarters · filed 2026-04-14 | -$1.07M derived: sum of 3 quarters · filed 2026-04-14 | -$1.38M 10-K · filed 2026-04-14 | |||
| 2025-09-30 | -$1.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$909.93K derived: sum of 2 quarters · filed 2025-11-14 | -$1.23M 10-Q · filed 2025-11-14 | -$765.28K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2025-06-30 | $204.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-18 | -$112.56K 10-Q · filed 2025-08-18 | $349.62K derived: sum of 3 quarters · filed 2026-05-15 | $550.21K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2025-03-31 | -$317.52K 10-Q · filed 2026-05-15 | $144.65K derived: sum of 2 quarters · filed 2026-05-15 | $345.24K derived: sum of 3 quarters · filed 2026-05-15 | -$168.41K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | $462.17K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | $662.77K derived: sum of 2 quarters · filed 2026-04-14 | $149.12K derived: sum of 3 quarters · filed 2026-04-14 | $204.34K 10-K · filed 2026-04-14 | |||
| 2024-09-30 | $200.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$313.06K derived: sum of 2 quarters · filed 2025-11-14 | -$257.83K 10-Q · filed 2025-11-14 | -$274.51K derived: sum of 4 quarters · filed 2025-11-14 | |||
| 2024-06-30 | -$513.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-18 | -$458.42K 10-Q · filed 2025-08-18 | -$475.10K derived: sum of 3 quarters · filed 2025-08-18 | -$728.61K derived: sum of 4 quarters · filed 2025-08-18 | |||
| 2024-03-31 | $55.23K 10-Q · filed 2025-05-15 | $38.55K derived: sum of 2 quarters · filed 2025-05-15 | -$214.96K derived: sum of 3 quarters · filed 2025-05-15 | $107.00K derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | -$16.68K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$270.19K derived: sum of 2 quarters · filed 2025-04-15 | $51.77K derived: sum of 3 quarters · filed 2025-04-15 | -$381.29K 10-K · filed 2025-04-15 | |||
| 2023-09-30 | -$253.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-15 | $68.44K derived: sum of 2 quarters · filed 2024-11-15 | -$364.62K 10-Q · filed 2024-11-15 | $285.12K derived: sum of 4 quarters · filed 2024-11-15 | |||
| 2023-06-30 | $321.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$111.11K 10-Q · filed 2024-08-14 | $538.63K derived: sum of 3 quarters · filed 2024-08-14 | $404.89K derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | -$433.06K 10-Q · filed 2024-05-15 | $216.68K derived: sum of 2 quarters · filed 2024-05-15 | $82.94K derived: sum of 3 quarters · filed 2024-05-15 | -$344.13K derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | $649.74K derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-16 | $516.00K derived: sum of 2 quarters · filed 2024-04-16 | $88.93K derived: sum of 3 quarters · filed 2024-04-16 | -$119.69K 10-K · filed 2024-04-16 | |||
| 2022-09-30 | -$133.74K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-03-26 | -$560.81K derived: sum of 2 quarters · filed 2024-03-26 | -$769.44K 10-Q/A · filed 2024-03-26 | -$1.16M derived: sum of 4 quarters · filed 2024-03-26 | |||
| 2022-06-30 | -$427.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-16 | -$635.69K 10-Q · filed 2023-08-16 | -$1.03M derived: sum of 3 quarters · filed 2023-08-16 | -$981.30K derived: sum of 4 quarters · filed 2023-08-16 | |||
| 2022-03-31 | -$208.63K 10-Q · filed 2023-05-09 | -$601.71K derived: sum of 2 quarters · filed 2023-05-09 | -$554.24K derived: sum of 3 quarters · filed 2023-05-09 | -$1.09M derived: sum of 4 quarters · filed 2023-05-09 | |||
| 2021-12-31 | -$393.08K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$345.61K derived: sum of 2 quarters · filed 2023-03-31 | -$880.92K derived: sum of 3 quarters · filed 2023-03-31 | -$1.18M 10-K · filed 2023-03-31 | |||
| 2021-09-30 | $47.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$487.83K derived: sum of 2 quarters · filed 2022-11-14 | -$787.45K 10-Q · filed 2022-11-14 | $565.37K derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | -$535.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$834.92K 10-Q · filed 2022-08-15 | $834.92K 10-Q · filed 2021-08-12 | $517.90K derived: sum of 3 quarters · filed 2022-08-15 | -$3.74M derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | -$299.62K 10-Q · filed 2022-05-16 | $1.05M derived: sum of 2 quarters · filed 2022-05-16 | -$3.21M derived: sum of 3 quarters · filed 2022-05-16 | $647.08K derived: sum of 4 quarters · filed 2022-05-16 | |||
| 2020-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-06 | -$2.91M derived: sum of 2 quarters · filed 2022-04-06 | $946.70K derived: sum of 3 quarters · filed 2022-04-06 | -$524.24K 10-K · filed 2022-04-06 | |||
| 2020-09-30 | -$4.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$406.13K derived: sum of 2 quarters · filed 2021-11-15 | -$1.88M 10-Q · filed 2021-11-15 | -$9.38K 10-Q · filed 2020-11-03 | -$1.87M derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | $3.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $2.38M 10-Q · filed 2021-08-12 | -$608.00 10-Q · filed 2020-08-11 | $2.39M derived: sum of 3 quarters · filed 2021-08-12 | $2.35M derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | -$1.47M 10-Q · filed 2021-05-18 | -$2.65K 10-Q · filed 2020-05-08 | -$1.47M derived: sum of 2 quarters · filed 2021-05-18 | -$1.50M derived: sum of 3 quarters · filed 2021-05-18 | -$1.50M derived: sum of 4 quarters · filed 2021-05-18 | ||
| 2019-12-31 | $5.32K derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-03-30 | -$32.30K derived: sum of 2 quarters · filed 2021-03-30 | -$31.67K derived: sum of 3 quarters · filed 2021-03-30 | -$30.60K 10-K · filed 2021-03-30 | |||
| 2019-09-30 | -$37.61K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2020-11-09 | -$36.98K derived: sum of 2 quarters · filed 2020-11-09 | -$35.92K 10-Q/A · filed 2020-11-09 | $263.57K derived: sum of 4 quarters · filed 2020-11-09 | |||
| 2019-06-30 | $629.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $1.69K 10-Q · filed 2020-08-11 | $301.18K derived: sum of 3 quarters · filed 2020-08-11 | $554.46K derived: sum of 4 quarters · filed 2020-08-11 | |||
| 2019-03-31 | $1.06K 10-Q · filed 2020-05-08 | $300.55K derived: sum of 2 quarters · filed 2020-05-08 | $553.83K derived: sum of 3 quarters · filed 2020-05-08 | $598.12K derived: sum of 4 quarters · filed 2020-05-08 | |||
| 2018-12-31 | $299.49K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-31 | $552.76K derived: sum of 2 quarters · filed 2020-03-31 | $597.06K derived: sum of 3 quarters · filed 2020-03-31 | -$463.60K 10-K · filed 2020-03-31 | |||
| 2018-09-30 | $253.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $297.57K derived: sum of 2 quarters · filed 2019-11-14 | -$763.09K 10-Q · filed 2019-11-14 | ||||
| 2018-06-30 | $44.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$1.02M 10-Q · filed 2019-08-09 | |||||
| 2018-03-31 | -$1.06M 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |